Lancastotug clinical trials
Also written AK127.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses lancastotug is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AK127
- 2
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses lancastotug is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid TumorsActive, not recruitingPhase 1/2AkesoNCT05951608Written as AK127 in combination with AK112
- A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid TumoursCompletedEarly Phase 1Akesobio Australia Pty LtdNCT05021120Written as AK127
- A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid TumorsStatus unknownPhase 1AkesoNCT05393063Written as AK127
Given beside what is tested · 1 — lancastotug is usual care or a partner of the new treatment
Codes
What other systems call lancastotug · ClinicalTrials.gg INT016969
- UNII (FDA) JP3KZB9R7CLANCASTOTUGOne source FDA
- NCI Thesaurus C184307LancastotugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | JP3KZB9R7C | LANCASTOTUG | One source FDA |
| NCI Thesaurus | C184307 | Lancastotug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.